Philochem is a Swiss subsidiary of the Philogen group (www.philogen.com), acting as discovery center for the group. Philochem’s activities focus on chemical pharmaceutical products and technologies. Read all
Philochem is happy to announce the start of an Innosuissecollaboration with ETH Zurich for the development of Macrocyclic DualPharmacophore DNA-Encoded Chemical Libraries. The partners will synthesize...
Read allPhilochem complements the pipeline of Philogen (which focuses on antibody products) with pharmaceutical products based on small organic molecules. Read all
Over the years the Philogen group has developed products and technologies in collaboration with leading pharmaceutical companies, including: